![](/img/cover-not-exists.png)
Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Comparative bone turnover marker and safety data
J.J. Body, M. Lichinitser, R.E. Coleman, B. BergströmVolume:
38
Year:
2006
Language:
english
DOI:
10.1016/j.bone.2006.01.014
File:
PDF, 51 KB
english, 2006